344 related articles for article (PubMed ID: 29367246)
1. Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.
Westrich JA; Warren CJ; Klausner MJ; Guo K; Liu CW; Santiago ML; Pyeon D
J Virol; 2018 Apr; 92(7):. PubMed ID: 29367246
[TBL] [Abstract][Full Text] [Related]
2. The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer.
Khalil MI; Yang C; Vu L; Chadha S; Nabors H; James CD; Morgan IM; Pyeon D
J Virol; 2024 Feb; 98(2):e0172623. PubMed ID: 38226814
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3A functions as a restriction factor of human papillomavirus.
Warren CJ; Xu T; Guo K; Griffin LM; Westrich JA; Lee D; Lambert PF; Santiago ML; Pyeon D
J Virol; 2015 Jan; 89(1):688-702. PubMed ID: 25355878
[TBL] [Abstract][Full Text] [Related]
4. DEK promotes HPV-positive and -negative head and neck cancer cell proliferation.
Adams AK; Hallenbeck GE; Casper KA; Patil YJ; Wilson KM; Kimple RJ; Lambert PF; Witte DP; Xiao W; Gillison ML; Wikenheiser-Brokamp KA; Wise-Draper TM; Wells SI
Oncogene; 2015 Feb; 34(7):868-77. PubMed ID: 24608431
[TBL] [Abstract][Full Text] [Related]
5. CUL2 overexpression driven by CUL2/E2F1/miR-424 regulatory loop promotes HPV16 E7 induced cervical carcinogenesis.
Xu J; Fang Y; Wang X; Wang F; Tian Q; Li Y; Xie X; Cheng X; Lu W
Oncotarget; 2016 May; 7(21):31520-33. PubMed ID: 27153550
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation.
Wang Z; Wakae K; Kitamura K; Aoyama S; Liu G; Koura M; Monjurul AM; Kukimoto I; Muramatsu M
J Virol; 2014 Jan; 88(2):1308-17. PubMed ID: 24227842
[TBL] [Abstract][Full Text] [Related]
7. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression.
Warren CJ; Westrich JA; Doorslaer KV; Pyeon D
Viruses; 2017 Aug; 9(8):. PubMed ID: 28825669
[TBL] [Abstract][Full Text] [Related]
8. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
Hatterschide J; Brantly AC; Grace M; Munger K; White EA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
[TBL] [Abstract][Full Text] [Related]
9. PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis.
Hatterschide J; Bohidar AE; Grace M; Nulton TJ; Kim HW; Windle B; Morgan IM; Munger K; White EA
Proc Natl Acad Sci U S A; 2019 Apr; 116(14):7033-7042. PubMed ID: 30894485
[TBL] [Abstract][Full Text] [Related]
10. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
11. The fanconi anemia pathway limits human papillomavirus replication.
Hoskins EE; Morreale RJ; Werner SP; Higginbotham JM; Laimins LA; Lambert PF; Brown DR; Gillison ML; Nuovo GJ; Witte DP; Kim MO; Davies SM; Mehta PA; Butsch Kovacic M; Wikenheiser-Brokamp KA; Wells SI
J Virol; 2012 Aug; 86(15):8131-8. PubMed ID: 22623785
[TBL] [Abstract][Full Text] [Related]
12. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Transcriptome Analysis of Human Papillomavirus 16-Infected Primary Keratinocytes Reveals Subtle Perturbations Mostly due to E7 Protein Expression.
Bienkowska-Haba M; Luszczek W; Zwolinska K; Scott RS; Sapp M
J Virol; 2020 Jan; 94(3):. PubMed ID: 31748387
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor.
Huh K; Zhou X; Hayakawa H; Cho JY; Libermann TA; Jin J; Harper JW; Munger K
J Virol; 2007 Sep; 81(18):9737-47. PubMed ID: 17609271
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
17. Activation of Src, Fyn and Yes non-receptor tyrosine kinases in keratinocytes expressing human papillomavirus (HPV) type 16 E7 oncoprotein.
Szalmás A; Gyöngyösi E; Ferenczi A; László B; Karosi T; Csomor P; Gergely L; Veress G; Kónya J
Virol J; 2013 Mar; 10():79. PubMed ID: 23497302
[TBL] [Abstract][Full Text] [Related]
18. RNA interference of human papillomavirus type 16 E7 increases HLA class I antigen expression in HaCaT-E7 cells.
Deng XM; Li W; Zhang X; Wang CX; Dong ZG; Zhang X; Zheng GX; Zhang XH; Zheng N; Wang LL; Du LT; Wang S
Int J Gynecol Cancer; 2011 Jan; 21(1):28-34. PubMed ID: 21330828
[TBL] [Abstract][Full Text] [Related]
19. HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout.
Abboodi F; Buckhaults P; Altomare D; Liu C; Hosseinipour M; Banister CE; Creek KE; Pirisi L
Virology; 2021 Feb; 554():9-16. PubMed ID: 33321328
[TBL] [Abstract][Full Text] [Related]
20. E6^E7, a novel splice isoform protein of human papillomavirus 16, stabilizes viral E6 and E7 oncoproteins via HSP90 and GRP78.
Ajiro M; Zheng ZM
mBio; 2015 Feb; 6(1):e02068-14. PubMed ID: 25691589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
